Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Atara Biotherapeutics gets OK to study multiple sclerosis treatment

By   /   Friday, January 12th, 2018  /   Comments Off on Atara Biotherapeutics gets OK to study multiple sclerosis treatment

    Print       Email
Atara Biotherapeutics announced Jan. 10 that it was cleared to enroll patients in a phase one clinical study to evaluate a T-cell immunotherapy treatment for multiple sclerosis. The company, which has its research and development headquarters in Westlake Village, got U.S. Food and Drug Administration approval for its investigational new drug application. The treatment uses…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →